Preparation method of (040) preferred orientation two-dimensional sheet decahedron-shaped monoclinic phase bismuth vanadate
A technology of monoclinic bismuth vanadate and preferred orientation, applied in chemical instruments and methods, vanadium compounds, inorganic chemistry, etc., can solve the problem of poor photocatalytic performance of monoclinic bismuth vanadate and difficult realization of monoclinic bismuth vanadate The structure directing agent has no problems such as retention, and achieves the effects of improving photocatalytic activity, low cost, and mild reaction conditions
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0024] Specific embodiment one: the preparation method steps of a kind of (040) preferred orientation two-dimensional sheet decahedral monoclinic phase bismuth vanadate of this embodiment are as follows:
[0025] ①. Weigh 48% to 52% of bismuth nitrate pentahydrate and 48% to 52% of sodium orthovanadate dodecahydrate respectively according to molar percentage;
[0026] 2. Take ethylenediaminetetraacetic acid, the mol ratio of the weighed ethylenediaminetetraacetic acid and the sodium orthovanadate dodecahydrate taken in step 1. is (1.1~1.5):1;
[0027] ③, using glycerol and deionized water to prepare a glycerol aqueous solution with a volume fraction of 15% to 45%, which is recorded as solution A;
[0028] 4. Dissolve the bismuth nitrate pentahydrate taken in step 1. in the solution A obtained in step 3. to prepare a bismuth nitrate solution with a concentration of 0.005mol / L to 0.03mol / L, which is designated as solution B;
[0029] 5. Dissolving the sodium orthovanadate dodecah...
specific Embodiment approach 2
[0034] Embodiment 2: The difference between this embodiment and Embodiment 1 is that in step ①, 50% of bismuth nitrate pentahydrate and 50% of sodium orthovanadate dodecahydrate are weighed by molar percentage. Other steps and parameters are the same as those in Embodiment 1.
specific Embodiment approach 3
[0035] Embodiment 3: The difference between this embodiment and Embodiment 1 or 2 is that the molar ratio of ethylenediaminetetraacetic acid to sodium orthovanadate dodecahydrate in step ② is (1.2-1.4):1. Other steps and parameters are the same as those in Embodiment 1 or Embodiment 2.
PUM
Property | Measurement | Unit |
---|---|---|
Specific surface area | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com